- Barrons.com•4 days ago
A downgrade from Stephens is pushingCore Laboratories (CLB) into the red Wednesday. Analyst Matthew Marietta cut his rating on the stock from Equal-Weight to Underweight with a $91 price target, nearly 20% below the stock’s level today.
- Market Realist•4 days ago
Tidewater rose 58.9% in the last five days. The large movements in the stock could help explain its high implied volatility.
- Motley Fool•4 days ago
Are you searching for some outstanding mid-cap stocks to add to your portfolio in December? Our Foolish contributors think Horizon Pharma, Core Laboratories NV, AutoNation, and Splunk could meet your needs.
CLB : Summary for Core Laboratories N.V. Common S - Yahoo Finance
Core Laboratories NV (CLB)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Bid||120.21 x 500|
|Ask||120.25 x 300|
|Day's Range||119.15 - 121.56|
|52 Week Range||96.30 - 121.56|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||81.53|
|Dividend & Yield||2.20 (1.83%)|
|1y Target Est||N/A|